Delivery Order SPE2DB24D8002-SPE2DB25FJMVP

Award Date 12/9/24
Potential Completion Date 12/10/24
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB24D8002
    Indefinite Delivery Contract
  • SPE2DB24D8002-SPE2DB25FJMVP
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $1,828.37 firm fixed-price contract is for the delivery of Fluticasone-Salmeterol 115-21 12GM, a pharmaceutical product, to support U.S. Armed Forces medical operations.

The contract is not set aside and is part of Dakota Drug, Inc.'s $999,999,999.00 Indefinite Delivery Contract (IDC) under the DLA Troop Support Medical's ECAT Generation V Program. This IDC allows the company to provide a comprehensive range of pharmaceutical products, medical supplies, and healthcare equipment to the U.S. military. The current delivery order has a performance period through December 10, 2024.

Generated 3/10/25, 9:47 AM